Zobrazeno 1 - 10
of 85
pro vyhledávání: '"CHB, chronic hepatitis B"'
Publikováno v:
Frontiers in Gastroenterology, Vol 3 (2024)
Background and aimsChronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) are leading causes of liver-related morbidity and mortality. The interaction between these two disease processes is poorly defined and the impact of NAFLD on H
Externí odkaz:
https://doaj.org/article/8dab092abcaa43bba659aeea37cb9876
Autor:
Haibing Gao, Xiangmei Wang, Huaxi Ma, Shenglong Lin, Dongqing Zhang, Wenjun Wu, Ziyuan Liao, Mengyun Chen, Qin Li, Minghua Lin, Dongliang Li
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
The role of genetic factors in the occurrence and progression of CHB (CHB) is still not fully explored. In recent years, genome-wide association studies on CHB patients have demonstrated that a large number of CHB-associated single nucleotide polymor
Externí odkaz:
https://doaj.org/article/a6b21caa7c0542c5814c99d35e850396
Autor:
Iñaki F. Trocóniz, Juan Jose Perez-Ruixo, Xavier Woot de Trixhe, Eduardo Asín-Prieto, Kim Stuyckens, Zinnia P. Parra-Guillen, José David Gómez Mantilla, Joris Vandenbossche
Publikováno v:
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 4997-5007 (2021)
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 4997-5007 (2021)
Graphical abstract
Highlights • Mechanistic model characterizing acute immune response and HBV system interactions. • Key role of the cellular and regulatory response triggering hepatitis B chronicity. • Modelling framework to easily incor
Highlights • Mechanistic model characterizing acute immune response and HBV system interactions. • Key role of the cellular and regulatory response triggering hepatitis B chronicity. • Modelling framework to easily incor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722cc9968b8cd803c557713cd9269da2
http://europepmc.org/articles/PMC8449028
http://europepmc.org/articles/PMC8449028
Autor:
Masaaki Shiina, Masatoshi Ishigami, Takanori Ito, Teiji Kuzuya, Asuka Kato, Norie Yamada, Takanobu Kato, Tetsuya Ishikawa, Masamichi Muramatsu, Mitsuhiro Fujishiro, Tomohisa Tanaka, Kohji Moriishi, Yoji Ishizu, Yoshiki Murakami, Hussein H. Aly, Hironori Nishitsuji, Kunitada Shimotohno, Asako Murayama, Takaji Wakita, Takashi Honda
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1583-1598 (2021)
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1583-1598 (2021)
Background & Aims To provide an adequate treatment strategy for chronic hepatitis B, it is essential to know which patients are expected to have a good prognosis and which patients do not require therapeutic intervention. Previously, we identified th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ffd0d58d93a8a01ec3dbbe756085ae
http://europepmc.org/articles/PMC8536788
http://europepmc.org/articles/PMC8536788
Publikováno v:
JHEP Reports, Vol 4, Iss 2, Pp 100398-(2022)
JHEP Reports
JHEP Reports
Summary: Insights into the immunopathogenesis of chronic HBV infections are fundamental in the quest for novel treatment approaches aimed at a functional cure. While much is known about the ineffective HBV-specific T-cell responses that characterise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d94254af9777a2d520ff3678645b2ff
http://www.sciencedirect.com/science/article/pii/S2589555921001749
http://www.sciencedirect.com/science/article/pii/S2589555921001749
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Harry L.A. Janssen, Laurens A. van Kleef, Bettina E. Hansen, Keyur Patel, Willem P. Brouwer, Robert A. de Man, Hannah S.J. Choi, Robert J. de Knegt, Milan J. Sonneveld
Publikováno v:
JHEP Reports, Vol 3, Iss 5, Pp 100350-(2021)
JHEP Reports
JHEP Reports, 3(5):100350. Elsevier
JHEP Reports
JHEP Reports, 3(5):100350. Elsevier
Background & Aims A recent consensus document has defined metabolic dysfunction-associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight, diabetes, and/or a combination of other metabolic risk factors. The clinical relevan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea513ed394452d7f95cca663d85f99f
http://www.sciencedirect.com/science/article/pii/S2589555921001269
http://www.sciencedirect.com/science/article/pii/S2589555921001269
Autor:
Shu Chun Chuang, I-Chien Wu, Tsung-Lung Tsai, Li-Ming Lien, Wen-Hao Huang, Chao A. Hsiung, Ming-Shiang Wu, Yen-Feng Chiu, Chang-Hua Chen, Tieh-Chi Chung, Chung-Chou Juan, Chih-Cheng Hsu, Yen-Tze Liu, Yu-Wen Yang, Wei-Lin Huang
Publikováno v:
Preventive Medicine Reports, Vol 23, Iss, Pp 101432-(2021)
Preventive Medicine Reports
Preventive Medicine Reports
Highlights • More patients with chronic hepatitis B (CHB) are surviving into old age. • The late-life health-related quality of life (HRQoL) they might experience remains unclear. • We repeatedly assessed HRQoL in a cohort of older adults with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abddec4e476593de2ab148cea2564538
http://www.sciencedirect.com/science/article/pii/S2211335521001224
http://www.sciencedirect.com/science/article/pii/S2211335521001224
Autor:
George V. Papatheodoridis, Harry L.A. Janssen, Florian van Boemmel, Margarita Papatheodoridi, Anastasia Kourikou, Cihan Yurdaydin, Bettina E. Hansen, Pietro Lampertico, John Vlachogiannakos, Ramazan Idilman, Savvoula Savvidou, John Goulis, Marta López-Gómez, Spilios Manolakopoulos, Thomas Berg, Nikolaos K. Gatselis, Maria Buti, Jose Luis Calleja, Rafael Esteban, George N Dalekos, Rhea Veelken, Vana Sypsa, Kostas Galanis, Alessandro Loglio
Publikováno v:
JHEP Reports
JHEP Reports, Vol 3, Iss 3, Pp 100290-(2021)
Scientia
JHEP Reports, 3(3):100290. Elsevier
JHEP Reports, Vol 3, Iss 3, Pp 100290-(2021)
Scientia
JHEP Reports, 3(3):100290. Elsevier
Background & Aims Recently, several risk scores for prediction of hepatocellular carcinoma (HCC) were developed in cohorts of treated Asian patients with chronic hepatitis B (CHB), but they have not been assessed in non-Asian patients. We evaluated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b54bf4ed65b784ec4c4c4980026192f
https://pure.eur.nl/en/publications/eaca8f96-a655-49b8-b491-412854979fbb
https://pure.eur.nl/en/publications/eaca8f96-a655-49b8-b491-412854979fbb
Publikováno v:
JHEP Reports
JHEP Reports, Vol 3, Iss 4, Pp 100295-(2021)
JHEP Reports, Vol 3, Iss 4, Pp 100295-(2021)
Background & Aims Current standard-of-care suppresses HBV replication, but does not lead to a functional cure. Treatment aiming to cure chronic hepatitis B (CHB) is believed to require the induction of strong cellular immune responses, such as by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa6a662c3c140792ac90ba2679e0c6e
http://europepmc.org/articles/PMC8203848
http://europepmc.org/articles/PMC8203848